1-4 of 4
Hervé Isola
Close
Sort by
Journal Articles

Photochemical Pathogen Inactivation Treatment of Human Plasma (amotosalen + UVA) Has No Major Impact on the Protein expression pattern Assessed by a 2-DIGE Proteomic Assay.

Jean-Pierre Cazenave, MD, PhD, Philippe Ohlmann, Hervé Isola, Christian Gachet, MD
Journal: Blood
Blood (2008) 112 (11): 1994.
https://doi.org/10.1182/blood.V112.11.1994.1994
Published: 2008
Journal Articles

Retention of Thrombin Generation Capacity of Therapeutic Apheresis Plasma Prepared with Amotosalen and UVA Light (INTERCEPT) Pathogen Inactivation.

Jean-Pierre Cazenave, MD, PhD, Pierre Netzer, Simone Schuhler, Catherine Ravanat, PhD, Hervé Isola, Daniel Kientz, MD, Christian Gachet, MD, PhD, Marie-Louise Wiesel, MD
Journal: Blood
Blood (2007) 110 (11): 4027.
https://doi.org/10.1182/blood.V110.11.4027.4027
Published: 2007
Journal Articles

Coagulation Factor Activity in Therapeutic Plasma Prepared from Whole Blood with Pathogen Inactivation (INTERCEPT ™ ) Treatment.

Jean-Pierre Cazenave, Hervé Isola, Marie-Louise Wiesel, Daniel Kientz, Michel Laforêt, Linda Pinkoski, Yasmin Singh, Laurence Corash
Journal: Blood
Blood (2006) 108 (11): 4149.
https://doi.org/10.1182/blood.V108.11.4149.4149
Published: 2006
Journal Articles

Coagulation Factors in Therapeutic Apheresis Plasma Held for 18 Hours at Ambient Temperature Prior to Pathogen Inactivation (INTERCEPT™).

Jean-Pierre Cazenave, Hervé Isola, Marie-Louise Wiesel, Daniel Kientz, Michel Laforêt, Marc Slaedts, Linda Pinkoski, Yasmin Singh, Laurence Corash
Journal: Blood
Blood (2006) 108 (11): 940.
https://doi.org/10.1182/blood.V108.11.940.940
Published: 2006